Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Pharmacol ; 973: 176537, 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38604546

ABSTRACT

Previous studies have shown that all kinin system is constitutively expressed in the normal and inflamed skin, with a potential role in both physiological and pathological processes. However, the understanding regarding the involvement of the kinin system in skin pigmentation and pigmentation disorders remains incomplete. In this context, the present study was designed to determine the role of kinins in the Monobenzone (MBZ)-induced vitiligo-like model. Our findings showed that MBZ induces higher local skin depigmentation in kinin receptors knockout mice (KOB1R, KOB2R and KOB1B2R) than in wild type (WT). Remarkably, lower levels of melanin content and reduced ROS generation were detected in KOB1R and KOB2R mice treated with MBZ. In addition, both KOB1R and KOB2R show increased dermal cell infiltrate in vitiligo-like skin, when compared to WT-MBZ. Additionally, lack of B1R was associated with greater skin accumulation of IL-4, IL-6, and IL-17 by MBZ, while KOB1B2R presented lower levels of TNF and IL-1. Of note, the absence of both kinin B1 and B2 receptors demonstrates a protective effect by preventing the increase in polymorphonuclear and mononuclear cell infiltrations, as well as inflammatory cytokine levels induced by MBZ. In addition, in vitro assays confirm that B1R and B2R agonists increase intracellular melanin synthesis, while bradykinin significantly enhanced extracellular melanin levels and proliferation of B16F10 cells. Our findings highlight that the lack of kinin receptors caused more severe depigmentation in the skin, as well as genetic deletion of both B1/B2 receptors seems to be linked with changes in levels of constitutive melanin levels, suggesting the involvement of kinin system in crucial skin pigmentation pathways.


Subject(s)
Melanins , Skin Pigmentation , Animals , Skin Pigmentation/drug effects , Mice , Melanins/metabolism , Melanins/biosynthesis , Mice, Knockout , Receptor, Bradykinin B1/metabolism , Receptor, Bradykinin B1/genetics , Cytokines/metabolism , Vitiligo/metabolism , Vitiligo/pathology , Receptor, Bradykinin B2/metabolism , Skin/metabolism , Skin/drug effects , Skin/pathology , Reactive Oxygen Species/metabolism , Mice, Inbred C57BL , Humans , Male
2.
Biomed Pharmacother ; 104: 151-157, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29772435

ABSTRACT

Psoriasis is a complex inflammatory and hyperproliferative skin disease. The pathogenesis and mechanisms involved are not completely understood, which makes treatment a difficult issue. Angiotensin II, the most active peptide of the renin-angiotensin system, seems to be involved in processes related to psoriasis pathogenesis, such as inflammation and cell proliferation. The aim of this study was to investigate the influence of renin inhibition on inflammation parameters and keratinocyte proliferation in a mouse model of chronic skin inflammation induced by croton oil. Aliskiren had anti-inflammatory effects by reducing levels of tumor necrosis factor-α and interleukin -6, and by inhibiting myeloperoxidase activity. Aliskiren also showed antiproliferative activity by reducing epidermal hyperplasia and proliferating cell nuclear antigen levels. Aliskiren treatment did not induce alterations in the cardiovascular system, normal skin thickness, and organ weight. These results suggest that aliskiren could be a valuable tool to be incorporated in the treatment of hyperproliferative and inflammatory skin disorders such as psoriasis.


Subject(s)
Amides/pharmacology , Antihypertensive Agents/pharmacology , Fumarates/pharmacology , Skin Diseases/drug therapy , Angiotensin II/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Cardiovascular System/drug effects , Cardiovascular System/metabolism , Disease Models, Animal , Female , Inflammation/drug therapy , Inflammation/metabolism , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice , Psoriasis/drug therapy , Psoriasis/metabolism , Renin/metabolism , Renin-Angiotensin System/drug effects , Skin Diseases/metabolism
3.
Dent Mater ; 32(6): 732-41, 2016 06.
Article in English | MEDLINE | ID: mdl-27087688

ABSTRACT

OBJECTIVE: To investigate the effect of collagen cross-links on the stability of adhesive properties, the degree of conversion within the hybrid layer, cytotoxicity and the inhibition potential of the MMPs' activity. METHODS: The dentin surfaces of human molars were acid-etched and treated with primers containing: 6.5wt% proanthocyanidin, UVA-activated 0.1wt% riboflavin, 5wt% glutaraldehyde and distilled water for 60s. Following, dentin was bonded with Adper Single Bond Plus and Tetric N-Bond; and restored with resin composite. The samples were sectioned into resin-dentin "sticks" and tested for microtensile bond strength (µTBS) after immediate (IM) and 18-month (18M) periods. Bonded sticks at each period were used to evaluate nanoleakage and the degree of conversion (DC) under micro-Raman spectroscopy. The enzimatic activity (P1L10 cross-linkers, P1L22 MMPs' activities) in the hybrid layer was evaluated under confocal microscopy. The culture cell (NIH 3T3 fibroblast cell line) and MTT assay were performed to transdentinal cytotoxicity evaluation. Data from all tests were submitted to appropriate statistical analysis (α=0.05). RESULTS: All cross-linking primers reduced the degradation of µTBS compared with the control group after 18M (p>0.05). The DC was not affected (p>0.213). The NL increased after 18M for all experimental groups, except for proanthocyanidin with Single Bond Plus (p>0.05). All of the cross-link agents reduced the MMPs' activity, although this inhibition was more pronounced by PA. The cytotoxicity assay revealed reduced cell viability only for glutaraldehyde (p<0.001). SIGNIFICANCE: Cross-linking primers used in clinically relevant minimized the time degradation of the µTBS without jeopardizing the adhesive polymerization, as well as reduced the collagenolytic activity of MMPs. Glutaraldeyde reduced cell viability significantly and should be avoided for clinical use.


Subject(s)
Dentin-Bonding Agents , Resin Cements , Acid Etching, Dental , Collagen , Dental Bonding , Dental Cements , Dental Leakage , Dentin , Humans , Materials Testing , Stress, Mechanical , Tensile Strength
4.
Photodiagnosis Photodyn Ther ; 12(3): 444-58, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26007240

ABSTRACT

BACKGROUND: Photodynamic therapy (PDT) is a technique that uses light and a photosensitizer, converting local molecular oxygen into singlet oxygen, which eliminates a target unhealthy tissue. It has been increasingly used for the treatment of several diseases including skin disorders. Psoriasis is a chronic inflammatory skin disease expressing immune and hyperproliferative features. OBJECTIVE: This study aimed to evaluate the effect of the photosensitizer 5,10-diphenyl-15,20-di(N-methylpyridinium-4-yl)porphyrin (Di-cis-Py+) in in vivo models whereby some psoriasis-like parameters could be investigated. METHODS: The antiinflammation and antiproliferative activities of Di-cis-Py+ photoactivated was measured by myeloperoxidase (MPO) and N-acetyl-ß-d-glucosaminidase (NAG) enzyme activity assay, measurement of IL-6, IL-1ß and TNF-α levels, evaluation of proliferating cell nuclear antigen (PCNA) levels by immunohistochemistry and by Western blot. RESULTS: Treatment involving PDT and Di-cis-Py+ resulted in reduction of edema, cellular infiltration, proinflammatory cytokines, as well as reduced hyperproliferation of the epidermis. All the evaluated parameters were promoted by topical application of phlogistic agents and are similar to that observed in lesions of psoriatic skin. CONCLUSION: The results shows the advantage of topical application, do not cause apparently photosensitivity and have effects comparable to dexamethasone, a first-line drug for the treatment of the disease.


Subject(s)
Inflammation Mediators/metabolism , Photochemotherapy/methods , Photosensitizing Agents/pharmacology , Porphyrins/pharmacology , Acetylglucosaminidase/metabolism , Animals , Cytokines/metabolism , Female , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Keratinocytes/drug effects , Mice , Peroxidase/metabolism , Photochemotherapy/adverse effects , Proliferating Cell Nuclear Antigen/metabolism , Psoriasis/drug therapy , Tumor Necrosis Factor-alpha/metabolism
5.
Am J Dent ; 27(6): 301-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25707083

ABSTRACT

PURPOSE: To evaluate the amount of hydrogen peroxide (HP) in the pulp chamber of teeth restored with composite resin and its cytotoxic effect on fibroblast cell line 3T3/NIH. METHODS: 112 human premolars were randomized into groups according to the combination of factors: Restoration: no restoration (NR); shallow (S); deep (D) and Activation by Light: yes (A) or no (NA). With exception of the groups Control and NR, Class V cavities (3 mm x 2 mm x 1 mm [S] and 3 mm x 2 mm x 2 mm [D]) were prepared and restored with composite resin. An acetate buffer was placed in the pulp chamber. The bleaching procedure was performed with 35% HP and activated or not with a LED/laser light. The buffer was mixed with leucocrystal violet and peroxide enzyme for the spectrophotometric evaluation of the optical density of the solution. For viability cell assays, different concentrations of HP were applied to fibroblast cell line. After 24 hours, the MTT and neutral red assays were evaluated. The lethal concentration of 50% of cells (LC50) was determined. Data were submitted to ANOVA and Tukey's test (α = 0.05). RESULTS: All experimental groups showed HP in the pulp chamber, but a higher amount was found in the pulp chamber of teeth with deep restorations (P = 0.026), regardless of light activation. The concentrations of HP that were found in the pulp chamber did not affect cell viability.


Subject(s)
Dental Restoration, Permanent , Hydrogen Peroxide/administration & dosage , Lasers , Tooth Bleaching , Animals , Fibroblasts/drug effects , Humans , Hydrogen Peroxide/toxicity , Mice , NIH 3T3 Cells
6.
Eur J Pharmacol ; 672(1-3): 88-95, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-22004612

ABSTRACT

Recent studies have indicated that nearly half of all surgical patients still have inadequate pain relief; therefore, it is becoming increasingly more important to understand the mechanisms involved in postoperative pain in order to be better treated. Previous studies have shown that incisions can cause mast cell degranulation. Thus, the aim of this study was to investigate the involvement of mast cells in a model of postoperative pain in mice. The depletion of mast cell mediators produced by pre-treatment with compound 48/80 (intraplantar (i.pl.)) widely (98 ± 23% of inhibition) and extensively (up to 96 h) prevented postoperative nociception and reduced histamine and serotonin levels (88 ± 4% and 68 ± 10%, respectively) in operated tissue. Furthermore, plantar surgery produced immense mast cell degranulation, as assessed by histology and confirmed by the increased levels of serotonin (three-fold higher) and histamine (fifteen-fold higher) in the perfused tissue, 1h after surgery. Accordingly, pre-treatment with the mast cell membrane stabilizer cromoglycate (200 µg/paw, i.pl.) prevented mechanical allodynia (inhibition of 96 ± 21%) and an increase in histamine (44 ± 10% of inhibition) and serotonin (73 ± 5% of inhibition) levels induced by plantar surgery. Finally, local treatment with H(1) (promethazine, 100 µg/paw, i.pl.), 5-HT(3) (ondansetron, 10 µg/paw, i.pl.) or 5-HT(2A) (ketanserin, 5 µg/paw, i.pl.) receptor antagonists partially decreased postoperative nociception in mice, but when co-administered together it completely reversed the mechanical allodynia in operated mice. Thus, mast cell activation mechanisms are interesting targets for the development of novel therapies to treat postoperative pain.


Subject(s)
Mast Cells/immunology , Pain, Postoperative/immunology , Animals , Cell Degranulation/drug effects , Disease Models, Animal , Histamine/metabolism , Histamine H1 Antagonists/pharmacology , Histamine H1 Antagonists/therapeutic use , Male , Mast Cells/metabolism , Mice , Nociception/drug effects , Pain, Postoperative/drug therapy , Pain, Postoperative/metabolism , Pain, Postoperative/psychology , Receptors, Histamine H1/metabolism , Serotonin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...